Keeps Biopharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	169,861	208,813	97,681	119,991	127,866	235,610
Market Cap Growth	-6.21%	113.77%	-18.59%	-6.16%	-45.73%	-23.77%
Enterprise Value	255,375	254,805	122,355	160,512	124,281	215,414
Last Close Price	8460.00	10400.00	5210.00	6400.00	6820.00	13100.00
PE Ratio	-	-	87.73	30.53	-	-
Forward PE	-	3.21	3.21	3.21	3.21	3.21
PS Ratio	1.00	1.23	0.77	1.30	8.75	55.30
PB Ratio	2.08	2.56	1.54	2.05	2.45	3.87
P/TBV Ratio	16.04	19.72	10.43	4.50	2.45	3.92
P/OCF Ratio	-	-	20.31	-	-	-
EV/Sales Ratio	1.50	1.50	0.96	1.74	8.50	50.56
EV/EBITDA Ratio	59.39	42.03	13.89	35.65	-	-
EV/EBIT Ratio	-	161.82	19.65	52.45	-	-
Debt / Equity Ratio	1.14	1.14	0.88	0.83	0.55	0.45
Debt / EBITDA Ratio	15.27	15.27	6.33	10.73	-	-
Net Debt / Equity Ratio	0.81	0.81	0.52	0.64	0.07	-0.22
Net Debt / EBITDA Ratio	10.89	10.89	3.72	8.31	-0.46	1.16
Net Debt / FCF Ratio	-1.41	-1.41	-18.32	-35.68	-3.76	1.57
Asset Turnover	0.85	0.85	0.90	0.91	0.16	0.05
Inventory Turnover	5.10	5.10	8.57	22.90	7.05	4.01
Quick Ratio	0.54	0.54	0.46	0.40	0.99	1.59
Current Ratio	1.15	1.15	0.82	0.84	1.35	2.10
Return on Equity (ROE)	-14.33%	-14.33%	2.64%	6.25%	-21.28%	-29.03%
Return on Assets (ROA)	0.49%	0.49%	2.74%	1.89%	-6.23%	-9.03%
Return on Invested Capital (ROIC)	1.17%	1.29%	3.10%	2.60%	-17.23%	-28.11%
Return on Capital Employed (ROCE)	1.10%	1.10%	7.70%	5.00%	-16.70%	-19.50%
Earnings Yield	-5.76%	-4.69%	1.14%	3.28%	-8.90%	-6.50%
FCF Yield	-27.58%	-22.44%	-1.83%	-0.87%	-0.75%	-3.60%
Buyback Yield / Dilution	-3.91%	-3.91%	-0.31%	-0.40%	-8.22%	-18.22%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.